Actualités



Retour


06/09/2019
Step Pharma Appoints Seasoned Drug Developer Dr. Andrew Parker as Chief Executive Officer
Paris, France, 6 September 2019 – Step Pharma, a biotech company developing novel drugs for autoimmune diseases, today announced the appointment of Andrew Parker, Ph.D., as Chief Executive Officer and member of the Supervisory Board. Dr. Parker joins Step Pharma with more than 20 years’ experience in various research and development roles at international pharmaceutical, biotech and start-up companies. He replaces founding CEO Geoffroy de Ribains. [...]

Télécharger le fichier pdf





X

X